BiotechTube

Quetiapine + Placebo

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

PTSD

Conditions

PTSD

Trial Timeline

Aug 1, 2003 → Dec 1, 2007

NCT ID
NCT00237393

About Quetiapine + Placebo

Quetiapine + Placebo is a approved stage product being developed by Johnson & Johnson for PTSD. The current trial status is completed. This product is registered under clinical trial identifier NCT00237393. Target conditions include PTSD.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00237393ApprovedCompleted

Competing Products

11 competing products in PTSD

See all competitors
ProductCompanyStageHype Score
SYN117 (nepicastat) + Placebo comparatorJohnson & JohnsonPhase 2
52
Lu AG06466 + PlaceboLundbeckPhase 1
30
Mifepristone 1200 mg daily + PlaceboCorcept TherapeuticsPhase 2
47
TNX-102 SLTonix PharmaceuticalsPhase 2
44
TNX-102 SL 5.6 mgTonix PharmaceuticalsPhase 3
69
TNX-102 SL + PlaceboTonix PharmaceuticalsPhase 2
44
TNX-102 SL + Placebo SL TabletTonix PharmaceuticalsPhase 3
69
TNX-102 SL + PlaceboTonix PharmaceuticalsPhase 2
44
TNX-102 SL + Placebo SL TabletsTonix PharmaceuticalsPhase 3
69
TNX-102 SLTonix PharmaceuticalsPhase 3
69
Ganaxolone + PlaceboBrain BiotechPhase 2
44

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85